| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Masimo Corp (MASI) has 10 insiders with recent SEC Form 4 filings, including 3 buys and 16 sells. MASI is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 130.9K | $23.35M | - | |
| VP | 41.1K | $7.33M | - | |
| COO | 30.3K | $5.40M | - | |
| COO | 13.8K | $2.46M | - | |
| Dir | 7.3K | $1.31M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 2, 2021 | Kiani Joe E74 | CEO And Chairman Of The Board | Sell | 45,842 | $291.15 | $13,346,917.39 | -6.7% | -24.2% | -56.3% | |
| Oct 27, 2021 | Kiani Joe E74 | CEO And Chairman Of The Board | Sell | 49,785 | $290.90 | $14,482,361.42 | -23.0% | -26.4% | -54.1% | |
| May 11, 2021 | McClenahan Thomas Samuel | EVP, Gen Counsel &Corp Sec | Buy | 500 | $214.40 | $107,200.00 | +2.2% | +27.5% | -43.0% | |
| May 3, 2021 | McClenahan Thomas Samuel | EVP, Gen Counsel &Corp Sec | Buy | 1,000 | $231.62 | $231,620.00 | +2.2% | +19.7% | -48.5% | |
| Apr 8, 2021 | Young Micah W | EVP &Chief Financial Officer | Sale+OE | 2,087 | $239.00 | $498,793.00 | -12.5% | +10.1% | -39.3% | |
| Jan 12, 2021 | Kiani Joe E74 | CEO And Chairman Of The Board | Sell | 3,403 | $280.32 | $953,942.57 | -4.1% | - | - | |
| Jan 11, 2021 | Reynolds Craig B | Director | Sale+OE | 10,000 | $279.74 | $2,797,412.00 | -69.9% | - | - | |
| Jan 11, 2021 | Kiani Joe E74 | CEO And Chairman Of The Board | Sell | 63,274 | $281.67 | $17,822,385.16 | -16.4% | - | - | |
| Dec 28, 2020 | Coleman Jon | Pres-ww Oem &Global Health | Sale+OE | 8,250 | $264.02 | $2,178,165.00 | -39.8% | - | - | |
| Dec 15, 2020 | Sampath Anand | EVP, Ops &Clinical Research | Sale+OE | 30,000 | $265.59 | $7,967,805.00 | -52.1% | - | - |